Girl, 6, suffers rare epidermolysis bullosa which makes skin blister at slightest touch
Rafaella Kopelan, from New York, was born with a rare and incurable genetic condition which means her skin is extremely fragile. (Source: the Mail online | Health)
Source: the Mail online | Health - June 12, 2014 Category: Consumer Health News Source Type: news

Scioderm Names Ronald Nardi, Ph.D. Chief Scientific Officer
DURHAM, N.C., June 12, 2014 -- (Healthcare Sales & Marketing Network) -- Scioderm, Inc. today announced the addition of Ronald Nardi, Ph.D. as the company's first chief scientific officer. Key points: Dr. Nardi brings more than 35 years of experienc... Biopharmaceuticals, PersonnelScioderm, epidermolysis bullosa, SD-101 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 12, 2014 Category: Pharmaceuticals Source Type: news

Two-year-old suffers from Epidermolysis Bullosa disorder which makes her skin fragile
Poppy Lovatt, from Stoke-on-Trent suffers from the Epidermolysis Bullosa disorder (EB) which makes her skin fall off at the slightest touch. (Source: the Mail online | Health)
Source: the Mail online | Health - April 28, 2014 Category: Consumer Health News Source Type: news

'I can't cuddle my son because it makes his skin fall off': Mother's heartbreak as boy, 8, battles rare condition which makes his skin blister at the slightest touch
WARNING GRAPHIC CONTENT: Rhys Williams, from Bolton, has a severe skin condition called epidermolysis bullosa which means he is covered in agonising blisters. (Source: the Mail online | Health)
Source: the Mail online | Health - January 22, 2014 Category: Consumer Health News Source Type: news

Scioderm begins Phase IIB trial of topical skin drug
US-based clinical-stage pharmaceutical firm Scioderm has started a Phase IIB trial of its novel topical therapy 'SD-101' for the treatment of non-healing wounds in patients with epidermolysis bullosa (EB). (Source: Drug Development Technology)
Source: Drug Development Technology - January 8, 2014 Category: Pharmaceuticals Source Type: news

Gene therapy for human skin disease produces long-term benefits
Stem cell-based gene therapy holds promise for the treatment of devastating genetic skin diseases, but the long-term clinical outcomes of this approach have been unclear. In a study online in the ISSCR's journal Stem Cell Reports, published by Cell Press, researchers evaluated a patient with a genetic skin disorder known as epidermolysis bullosa (EB) nearly seven years after he had undergone a gene therapy procedure as part of a clinical trial. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 3, 2014 Category: Consumer Health News Tags: Dermatology Source Type: news

Stem Cells in Gene Therapy of Junctional Epidermolysis BullosaStem Cells in Gene Therapy of Junctional Epidermolysis Bullosa
Epidermal stem cells can be used effectively for gene therapy in patients with junctional epidermolysis bullosa, researchers from Italy report. Reuters Health Information (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 31, 2013 Category: Dermatology Tags: Dermatology News Source Type: news

Gene therapy for human skin disease produces long-term benefits
(Cell Press) In a study publishing in the journal Stem Cell Reports, researchers evaluated a patient with a genetic skin disorder known as epidermolysis bullosa nearly seven years after he had undergone a gene therapy procedure as part of a clinical trial. The study revealed that a small number of skin stem cells transplanted into the patient's legs were sufficient to restore normal skin function, without causing any adverse side effects. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 26, 2013 Category: Global & Universal Source Type: news

Tragic plight of five-month-old 'blister baby' who cannot be cuddled for fear it will pull her skin off
WARNING GRAPHIC CONTENT: Lexie-Mae Bravender, from Manchester, suffers from Epidermolysis Bullosa (EB), an incurable condition that causes the skin to tear and blister very easily. (Source: the Mail online | Health)
Source: the Mail online | Health - June 24, 2013 Category: Consumer Health News Source Type: news

Researchers Find Novel Gene Correction Model For Painful Skin Condition Epidermolysis Bullosa
A research team led by pediatric blood and marrow transplantation experts Mark Osborn, Ph.D. and Jakub Tolar, M.D., Ph.D. from the Masonic Cancer Center, University of Minnesota, have discovered a remarkable new way to repair genetic defects in the skin cells of patients with the skin disease epidermolysis bullosa... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - June 11, 2013 Category: Consumer Health News Tags: Dermatology Source Type: news

U of M researchers find novel gene correction model for epidermolysis bullosa
(University of Minnesota Academic Health Center) A research team led by pediatric blood and marrow transplantation experts Mark Osborn, Ph.D. and Jakub Tolar, M.D., Ph.D. from the Masonic Cancer Center, University of Minnesota, have discovered a remarkable new way to repair genetic defects in the skin cells of patients with the skin disease epidermolysis bullosa. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 6, 2013 Category: Global & Universal Source Type: news

Shire Regenerative Medicine Initiates Phase 3 Study Of ABH001 For Patients With Epidermolysis Bullosa
Shire plc (LSE: SHP, NASDAQ: SHPG), have announced the initiation of a Phase 3 study designed to evaluate the efficacy and safety of ABH001, its dermal substitute therapy, for the treatment of non-healing wounds in patients with Epidermolysis Bullosa (EB), a group of rare genetic skin disorders that begin to manifest at birth or early childhood and occur in approximately 19 per 1 million live births in the US. [i]� � "People affected by EB suffer skin blisters and almost constant, acute pain and scarring," said the study's Principal Investigator, H... (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 12, 2013 Category: Consumer Health News Tags: Dermatology Source Type: news

The little boy with tissue-thin skin who could be killed by the smallest bump
Hugo Tornqvist, from Karlskrona, Sweden, suffers from Junctional Herlitz Epidermolysis Bullosa. His entire body, both inside and out, is covered in sores and blisters. (Source: the Mail online | Health)
Source: the Mail online | Health - February 7, 2013 Category: Consumer Health News Source Type: news

Shire Acquires Lotus Tissue Repair, Inc.
HGT Pipeline Enhanced with Protein Replacement Therapy Being Investigated for the Treatment of Dystrophic Epidermolysis Bullosa LEXINGTON, Massachusetts, January 8, 2013 /PRNewswire/ --Shire plc (LSE: SHP, NASDAQ: SHPG), announces that it has... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 8, 2013 Category: Pharmaceuticals Source Type: news

Stem Cells for Cell-Based Therapies
The world of stem cells We know the human body comprises many cell types (e.g., blood cells, skin cells, cervical cells), but we often forget to appreciate that all of these different cell types arose from a single cell—the fertilized egg. A host of sequential, awe-inspiring events occur between the fertilization of an egg and the formation of a new individual: Embryonic stem (ES) cells are also called totipotent cells. The first steps involve making more cells by simple cell division: one cell becomes two cells; two cells become four cells, etc. Each cell of early development is undifferentiated; that is, it is...
Source: ActionBioscience - December 28, 2012 Category: Science Authors: Ali Hochberg Source Type: news